Evidence for the Superiority of Immunosuppressive Drugs and Prednisone over Prednisone Alone in Lupus Nephritis
about
Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosusTreatment for lupus nephritisCyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosusTreatment for lupus nephritisTreatment of primary Sjögren syndrome.Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively.New approaches to treating systemic lupus erythematosusRecent clinical trials in lupus nephritis.Combination treatment in autoimmune diseases: systemic lupus erythematosus.Treatment of vasculitis.Outcome of the acute glomerular injury in proliferative lupus nephritis.Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study.New treatment strategies for proliferative lupus nephritis: keep children in mind!Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis.Pharmacotherapy of scleritis: current paradigms and future directions.Treatment of proliferative lupus nephritis: a slowly changing landscape.Systemic lupus erythematosus: a genetic review for advanced practice nurses.Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases.Towards new avenues in the management of lupus glomerulonephritis.Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease.The safety of pharmacological treatment options for lupus nephritis.A five consecutive years' study of renal function outcome among biopsy proven lupus nephritis patients in Southern Iran.Systemic lupus erythematosus. Controversies in management.Meta-analysis in transfusion medicine.Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study.Nephrology, dialysis and transplantation.Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine.Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study.Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone.Intravenous cyclophosphamide for lupus nephritis in Thai children.Sample size considerations for superiority trials in systemic lupus erythematosus (SLE).An overview of the treatment of childhood SLE.Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus.Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial.Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers.
P2860
Q24200954-49CA8B2C-81EB-4425-92EA-FDC37BDC7761Q24202572-825DA654-7605-458E-A4FC-698B0F333941Q24246092-66349AA3-4055-4922-990C-6CEB1062511FQ24247408-684A1375-6A81-4E6D-8EA5-61A16ECD128BQ30249011-144BA565-67E9-459C-B68E-4DF91F661AA9Q33562068-9BE3CED0-A1F6-4816-B52A-A721DD734AB0Q33614633-31C0CB43-DE5A-4D4A-8936-F606F0A3E23BQ33924437-C1EC86C6-D5D7-47DD-AFF5-140CE64C233EQ34309764-CB14E307-CCF2-4850-8481-5DA730A7524BQ34403507-EABDB106-7341-4CE7-B676-AE06BB691D6AQ35814458-DF32BF61-BF63-44CE-B1CA-1E6C04EEB3DEQ36157955-9AD27C4F-5088-4910-904C-D5494C644305Q36915693-D53530A8-7E32-400A-BCBC-25C01B61F7EFQ37352584-8D4E7EE1-CA5E-4080-86F3-1B3A5035A780Q37466204-D6628382-7F42-4077-8B57-3316DC4B3663Q37822658-FC2BF0BB-CD28-45B0-A930-728D28EC2438Q37965222-B2DC71B2-B62B-4CC5-ACD2-66F74BA4CD04Q38092131-22B78206-7ACE-4C02-9A9B-0F790C15D3A0Q38686467-ADED9AAB-6506-4863-8788-48C552930EB5Q38692232-5BD1FBB9-5D1C-44D9-81C6-4C112B52A201Q38829637-B636110B-C6AC-46C5-BCB4-0A9E9D084A82Q38831835-8BF70DF7-1131-4163-80E6-D833A80F74EBQ39656638-E5D7BB55-69C0-4926-81A6-016B17D2BBE1Q41448964-5E0EA012-D4E7-445C-8B74-9B5B4353DD69Q42458610-032D758C-559B-4F33-8D57-294709927D99Q42973858-D7F17583-7D85-4252-A170-836D865A0B9DQ43959861-C72D1C99-FD9E-4406-89B2-DED814C1C94CQ44112212-2DDE2271-B8FF-4522-A4BB-F095B9610E22Q44428095-C804101C-DDB6-44DB-B37C-070610C63CD4Q45129675-E37CD882-7587-409D-B1B9-E7D56B775FDFQ47253208-A6368243-454D-4A81-B693-461FB0DCC895Q47625953-699A8B09-2111-4A33-8572-3E90B4DDA5A0Q53902963-98E2D10B-45A2-4D58-9494-522019B2430DQ53920423-53AD1757-88A2-41F1-BCE8-7DCCF087FCBDQ54059237-1C570267-69AE-4C19-8527-703893B296F8
P2860
Evidence for the Superiority of Immunosuppressive Drugs and Prednisone over Prednisone Alone in Lupus Nephritis
description
article
@en
im Dezember 1984 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 1984
@uk
name
Evidence for the Superiority o ...... isone Alone in Lupus Nephritis
@en
Evidence for the Superiority o ...... isone Alone in Lupus Nephritis
@nl
type
label
Evidence for the Superiority o ...... isone Alone in Lupus Nephritis
@en
Evidence for the Superiority o ...... isone Alone in Lupus Nephritis
@nl
prefLabel
Evidence for the Superiority o ...... isone Alone in Lupus Nephritis
@en
Evidence for the Superiority o ...... isone Alone in Lupus Nephritis
@nl
P1476
Evidence for the superiority o ...... . Results of a pooled analysis
@en
P2093
Anderson J
P304
P356
10.1056/NEJM198412133112402
P407
P577
1984-12-01T00:00:00Z